MFP
IHE icon

Meramec Financial Planners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Meramec Financial Planners’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Buy
212
+1
+0.5% +$90 0.01% 302
2026
Q1 		$18.6K Buy
211
+1
+0.5% +$88 0.01% 282
2025
Q4 		$19K Buy
+210
New +$16.8K 0.01% 283

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Meramec Financial Planners's IHE Position: Q2 2026 in Review

Meramec Financial Planners increased its iShares US Pharmaceuticals ETF (IHE) stake by 0.47% in Q2 2026, buying an estimated $90 and bringing the position to 212 shares worth $21.8K. The position accounts for 0.01% of the portfolio, ranked #302.

Meramec Financial Planners first reported a position in IHE in Q4 2025 and has held it in 3 quarters since. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Meramec Financial Planners held 212 shares of iShares US Pharmaceuticals ETF worth $21.8K as of Q2 2026.
  • Meramec Financial Planners bought 1 iShares US Pharmaceuticals ETF share in Q2 2026, an estimated $90.
  • iShares US Pharmaceuticals ETF made up 0.01% of Meramec Financial Planners's portfolio in Q2 2026, its #302 holding.
  • Meramec Financial Planners first reported a position in iShares US Pharmaceuticals ETF in Q4 2025 and has held it in 3 quarters since.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.